Market News

The precious metalwas near $4,500 an ounce, having risen almost 3% amid uncertainty over a potential ceasefire agreement.

Expert verdict: Top analysts weigh in on L&T, Tata Motors PV, RIL, Piramal Pharma and more

The Indian currency may continue to weaken in a calibrated manner, with levels around over 95 per US dollar appearing increasingly likely, analysts say.

While the equity markets slipped, oil prices continues to edge higher. The benchmark, Brent Crude futures, advanced 3.2% to more than $111 a barrel.

Currently, liquidity in the banking system is estimated to be in surplus of around Rs 48,698.38 crore as on March 26.

Analysts said bullion prices remained volatile as movements in crude oil and global cues influenced investor sentiment.

There are currently 26 draft IPO offer documents under review by SEBI, includingSBI Funds Management Ltd.,Deepa Jewellers Ltd., andMoneyview Ltd.

The interim dividend shall be paid within a period of 30 days from the declaration, said Sundaram-Clayton.

Stock Market Crash Today: The blue-chip indices are set to log their fifth consecutive weekly loss, the longest stretch since August.

This comes on the back of the ongoing conflict in the Middle East, although G Chokkalingam, Founder & MD, Equinomics Research, believes the rupee could return to 90 levels once the war is over.

The BSE Sensex slumped 1.2% during the this holiday-shortened week and the NSE Nifty declined 1.3%.

As market volatility persists, an expert outlines a clear divide in strategy — long-term investors may look at gradual buying, while short-term traders face a different approach.

The dispute centres on whether the name "Olymviq" is too similar to "Ozempic", a drug used for diabetes and weight management, raising concerns over patient safety and prescribing errors.

Amir Chand Jagdish Kumar IPO has a book-built issue of Rs 440 crore.

Large global players like Accenture and Cognizant have already built strong vertical capabilities in healthcare, allowing them to offer end-to-end solutions.

Siddharth Mittal resigned as CEO and MD of Biocon on Friday.

Mittal will step down from his role at the close of business hours on March 31 to transition into another leadership role within the Biocon Group.

The Initial Public Offering (IPO) of the Central Mine Planning & Design Institute (CMPDI) is scheduled to list on the stock exchanges (NSE and BSE) next week. Latest GMP indicates an estimated listing price of Rs 180.

The interim dividend record date is April 2, 2026, with payments to be made within 30 days. Dividend income will be subject to TDS as per Income Tax Act provisions.

Q4 FY26 Results Calendar: The three Indian IT majors are set to declare their quarterly results next month.